Non-steroidal anti-inflammatory drugs and cardiovascular risk : a rheumatologist's reply

Date
2007-12
Authors
Whitelaw, David
Journal Title
Journal ISSN
Volume Title
Publisher
Health and Medical Publishing Group (HMPG)
Abstract
To the Editor: The cyclo-oxygenase-2 (COX-2) inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs) have been the subject of scrutiny generated mainly by evidence suggesting that rofecoxib is associated with increased cardiovascular risk. Chin and Commerford1 have summarised some of the large volume of data; however, a critical review of published work yields interesting insights.
Description
Letter
The original publication is available at http://www.samj.org.za
Keywords
Nonsteroidal anti-inflammatory agents, Cardiovascular system -- Diseases
Citation
Whitelaw, D. 2007. Non-steroidal anti-inflammatory drugs and cardiovascular risk - a rheumatologist's reply. South African Medical Journal, 97(12):1230.